MicroRNA-495 Confers Increased Sensitivity to Chemotherapeutic Agents in Gastric Cancer via the Mammalian Target of Rapamycin (mTOR) Signaling Pathway by Interacting with Human Epidermal Growth Factor Receptor 2 (ERBB2)

BACKGROUND: In recent years, the incidence of gastric cancer (GC) has been increasing worldwide. Emerging evidence shows that microRNAs (miRs) may be involved in the pathogenesis of GC. Thus, this study explored the mediatory role of miR-495 in GC chemosensitivity, and investigated the mechanism by...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Na, Han, Mei, Zhou, Ning, Tang, Yong, Tang, Xu-Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2018
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122272/
https://www.ncbi.nlm.nih.gov/pubmed/30147110
http://dx.doi.org/10.12659/MSM.909458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122272/
https://www.ncbi.nlm.nih.gov/pubmed/30147110
http://dx.doi.org/10.12659/MSM.909458

Ejemplares similares